This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Macular Degeneration
and you are
over 50
years old
1
2
This is a medium phase trial determining
the safety and dosage of the new treatment, as well as its efficacy.
Show me locations

The purpose

Hypothesis: external electrical stimulation of the retina with low level electrical currents improves visual acuity in subjects with age-related dry macular degeneration.

Provided treatments

  • Device: Tesmac
  • Device: Sham Tesmac device
Tris trial is registered with FDA with number: NCT01600300. The sponsor of the trial is Acuity Medical International, Inc. and it is looking for 40 volunteers for the current phase.
Official trial title:
A Double-Blind, Placebo-Controlled Feasibility Study to Evaluate the Efficacy of TESMAC™ (Transcutaneous Electrical Stimulation of the Macula)